Impact of the Covid-19 Pandemic on Colorectal Cancer Surgery in Madrid
Authors:
- Maria Labalde MartínezMMMaria Labalde Martínez
- Francisco Javier García BordaFBFrancisco Javier García Borda
- Cristina Narvaez ChavezCCCristina Narvaez Chavez
- Alfredo Vivas LopezALAlfredo Vivas Lopez
- Oscar García VillarOVOscar García Villar
- Felipe de La Cruz VigoFVFelipe de La Cruz Vigo
- Eduardo Ferrero HerreroEHEduardo Ferrero Herrero
Open Access
- 3 June 2021
- journal article
- research article
- Published by Georg Thieme Verlag KG in Journal of Coloproctology
- Vol. 41 (03) , 257-264
Abstract
Introduction The Covid-19 pandemic has had an important impact on colorectal cancer surgery, for hospital resources had to be redistributed in favour of Covid-19 patients. The aim of the present study is to analyze our results in colorectal oncologic surgery during the Covid-19 pandemic in patients with and without perioperative SARS-CoV-2 infection. Methods In total, 32 patients (19 male and 13 female patients), with a mean age of 64 years (range: 57.2 to 69.5 years) with colorectal cancer underwent surgery under the recommendations of surgical societies included in a protocol. Data collection included clinical characteristics (gender, age, body mass index, American Society of Anesthesiologists score, tumor location, preoperative staging, lymphopenia), data related to SARS-CoV-2 infection (postoperative symptoms, diagnostic tests), operative details (surgical procedure, approach, duration, stoma), pathological outcomes (tumor stage, number of lymph nodes harvested, distal and circumferential radial margins, quality of the total mesorectal excision), and surgical outcomes (morbidity, mortality, hospital stay, and the rates of reoperation and readmission). Results A total of 3 (9.4%) patients who underwent colorectal surgery during the Covid-19 pandemic were infected by SARS-CoV-2 in the postoperative period. Chronic obstructive pulmonary disease was associated with Covid-19 (6.2% versus 33.3%; p = 0.042), and surgical morbidity was higher among Covid-19 patients (100% versus 37.9%; p = 0.039). There were not significant differences between COVID-19 patients and non-COVID-19 patients in relation to the rest of the analyzed outcomes. Conclusion During the Covid-19 pandemic, colorectal cancer surgery should be performed according to the recommendations of surgical societies. However, Covid-19 patients could present a higher morbidity rate.Keywords
This publication has 23 references indexed in Scilit:
- Managing COVID-19 in Surgical SystemsAnnals of Surgery, 2020
- Minimally Invasive Surgery and the Novel Coronavirus Outbreak: Lessons Learned in China and ItalyAnnals of Surgery, 2020
- How Coronavirus Disease 2019 Outbreak Is Impacting Colorectal Cancer Patients in Italy: A Long Shadow Beyond InfectionDiseases of the Colon & Rectum, 2020
- Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, ChinaJAMA, 2020
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort studyThe Lancet, 2020
- What we do when a COVID-19 patient needs an operation: operating room preparation and guidanceCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- Does A Longer Waiting Period After Neoadjuvant Radio-chemotherapy Improve the Oncological Prognosis of Rectal Cancer?Annals of Surgery, 2019
- Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trialThe Lancet Oncology, 2017
- Classification of Surgical ComplicationsAnnals of Surgery, 2004